Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for CVS Health Corporation (CVS:NYSE), powered by AI.
CVS Health Corporation is currently trading at $76.43. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for CVS Health Corporation on Alpha Lenz.
View CVS Health Corporation's valuation metrics on Alpha Lenz.
“CVS Health Corporation's ROE is 2.3%. Explore profitability and growth together.”
Ask for details →CVS Health Corporation is a leading health services company in the United States, offering a comprehensive range of services aimed at improving healthcare accessibility and convenience. Primarily known for its extensive network of pharmacies, CVS Health operates thousands of retail locations nationwide. These outlets provide prescription medications, over-the-counter drugs, health and wellness products, and immunization services. Beyond retail, CVS Health plays a significant role in the healthcare sector through its pharmacy benefit management division, Caremark, which administers prescription drug plans for insurers and employers. Additionally, the company owns Aetna, a major health insurance provider, aligning its services across retail, pharmacy benefits, and insurance solutions to deliver integrated healthcare experiences. With its broad reach and diverse healthcare offerings, CVS Health Corporation holds a critical place in the healthcare market, continuously working to streamline and enhance the delivery of medical services across the country.
“CVS Health Corporation's ROE is 2.3%. Explore profitability and growth together.”
Ask for details →CVS Health Corporation (ticker: CVS) is a company listed on NYSE in the Healthcare sector (Healthcare Plans). It has approximately 219,000 employees.
The current price is $76.43 with a P/E ratio of -x and P/B of -x.
ROE is 2.35% and operating margin is 2.58%. Annual revenue is $402.1B.